Diversity of hepatitis C virus genotypes among intravenous heroin users in Taiwan

American Journal of the Medical Sciences

Volumn 341, Issue 2, 2011, Pages 110-112

  Liao, Kuan Fu ^a   Lai, Shih Wei ^b   Lin, Chung Yi ^a   Huang, Chi Hung ^a   Lin, Yi Ying ^a  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Genotype; Hepatitis C; Heroin; Intravenous drug users

Indexed keywords

HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CROSS-SECTIONAL STUDY; DIAGNOSTIC VALUE; GENOTYPE; GROUPS BY AGE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; POLYMERASE CHAIN REACTION; PRISON; SEROPREVALENCE; SPECIES DISTRIBUTION; TAIWAN; VIRUS GENE; VIRUS STRAIN;

EID: 79951512808     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181f5582f     Document Type: Article

References (29)

1. Department of Health, Taiwan: Main Causes of Death in 2008. Available at: http://www.doh.gov.tw/CHT2006/DM/DM2-2-p02.aspx?class-no=440&now-fod-list- no=10642&level-no=3&doc-no=73104. Accessed on April 24, 2010.
2. Chen DS, Wang JT, Chen PJ, et al. Hepatitis C virus infection in Taiwan. Gastroenterol Jpn 1991;26(suppl 3):164-6.
3. Tsai JF, Chang WY, Jeng JE, et al. Hepatitis C virus infection as a risk factor for non-alcoholic liver cirrhosis in Taiwan. J Med Virol 1993;41:296-300.
4. Tai DI, Chen CH, Chang TT, et al. Eight-year nationwide survival analysis in relatives of patients with hepatocellular carcinoma: role of viral infection. J Gastroenterol Hepatol 2002;17:682-9.
5. Lee SD, Tsai YT, Hwang SJ, et al. Posttransfusion non-A, non-B hepatitis following cardiovascular surgery in Taiwan. J Med Virol 1991;33:188-92.
6. Seeff LB. Natural history of hepatitis C. Hepatology 1997;6:21S-8S. (Pubitemid 27388067)
7. Dusheiko G, Schmilovitz-Weiss H, Brown D, et al. Hepatitis C virus genotypes: an investigation oftype-specific differences in geographic origin and disease. Hepatology 1994;19:13-8. (Pubitemid 24020465)
8. Pozzato G, Kaneko S, Moretti M, et al. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 1994;43:291-6. (Pubitemid 24227603)
9. Lau JY, Mizokami M, Kolberg JA, et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995;171:281-9.
10. Hwang SJ, Lee SD, Lu RH, et al.Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C. J Med Virol 2001;65:505-9.
11. De Mitri MS, Poussin K, Baccarini P, et al. HCV associated liver cancer without cirrhosis. Lancet 1995;345:413-5.
12. Watson JP, Brind AM, Chapman CE, et al. Hepatitis C virus: epidemiology and genotypes in the north east of England. Gut 1996; 38:269-76. (Pubitemid 26046825)
13. Yu ML, Chuang WL, Chen SC, et al. Changing prevalence of hepatitis c virus genotypes: molecular epidemiology and clinical impli-cations in the hepatitis c virus hyperendemic areas and a tertiary referral center in Taiwan. J Med Virol 2001;65:58-65.
14. Wu JS, Lee HF, Hsiau HL, et al. Genotype distribution of hepatitis C virus infection in Taiwan. J Med Virol 1994;44:74-9.
15. Yu ML, Chuang WL, Lu SN, et al. The genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection in southern Taiwan. Kaohsiung J Med Sci 1996;12:605-12.
16. Liou YW, Chou P, Chen YM. Genotypic analysis of HCV infection in Kinmen. J Microbiol Immunol Infect 2000;33:149-53.
17. Guimarães T, Granato CF, Varella D, et al. High prevalence of hepatitis C infection in a Brazilian prison: identification ofrisk factors for infection. Braz J Infect Dis 2001;5:111-8.
18. Nyamathi AM, Dixon EL, Robbins W, et al. Risk factors for hepatitis C virus infection among homeless adults. J Gen Intern Med 2002;17: 134-43. (Pubitemid 34595462)
19. Gates JA, Post JJ, Kaldor JM, et al. Risk factors for hepatitis C infection and perception ofantibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia. J Urban Health 2004;81:448-52. (Pubitemid 39128280)
20. Fox RK, Currie SL, Evans J, et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis 2005;41:177-86. (Pubitemid 40962498)
21. Liu JY, Lin HH, Liu YC, et al. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan. Clin Infect Dis 2008;46:1761-8.
22. Lee YM, Lin HJ, Chen YJ, et al. Molecular epidemiology of HCV genotypes among injection drug users in Taiwan. Full-length sequences of two new subtype 6w strains and a recombinant form-2b6w. J Med Virol 2010;82:57-68.
23. Schroter M, Zollner B, Schafer P, et al. Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays. J Clin Microbiol 2001;39:765-8. (Pubitemid 32150858)
24. Feucht HH, Schroter M, Zollner B, et al.The influence of age on the prevalence of hepatitis C virus subtypes 1a and 1b. J Infect Dis 1997;175:685-8. (Pubitemid 27086176)
25. Alter MJ, Seeff LB, Bacon BR, et al. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Ann Intern Med 2004;141:715-7. (Pubitemid 39434844)
26. Basaras M, Lombera N, de las Heras B, et al. Distribution of HCV genotypes in patients infected by different sources. Res Virol 1997;148: 367-73. (Pubitemid 27487866)
27. Dal Molin G, Ansaldi F, Biagi C, et al. Changing molecular epide-miology of hepatitis C virus infection in Northeast Italy. J Med Virol 2002;68:352-6.
28. Touceda S, Pereira M, Agulla A. [Prevalence of hepatitis C virus genotypes in the area of El Ferrol (La Coruña, Spain).] Enferm Infecc Microbiol Clin 2002;20:200-4.
29. Yu ML, Chuang WL. Treatment of chronic hepatitis C in Asia: when East meets West. J Gastroenterol Hepatol 2009;24:336-45.